ApicHope Pharmaceutical (SHE:300723) subsidiary Guangzhou ApicHope will sign a clinical research commissioning contract with Boji Medical Technology (SHE:300404) for 6.5 million yuan, according to a Saturday disclosure to the Shenzhen Stock Exchange.
Boji will perform clinical research for the APH04935 tablets for weight management and obesity.
Shares rose 4% during afternoon trading on Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.